Red Violet: Depressed Valuation Does Not Reflect Fundamentals
Red Violet remains a BUY, with growth catalysts in place and evidence of the thesis materializing through 2026. Q1 earnings reinforce the company's long-term growth trajectory, validating prior expectations despite recent stock underperformance. RDVT's current valuation is depressed due to broader AI sentiment, presenting a compelling entry point for patient investors.
RDVT - Red Violet, Inc.